Kassiotis lab

Retroviral Immunology Laboratory

 Publications

Numerous retroviral particles (pseudocoloured) endogenously produced by lymphoma cells in an immune-deficient mouse.

Publications

Year published

Research topics

Publication type

Journal

Displaying 1 - 20 of 97
Last updated : 02 October 2023 03:37

Neutralising immunity to omicron sublineages BQ.1.1, XBB, and XBB.1.5 in healthy adults is boosted by bivalent BA.1-containing mRNA vaccination and previous Omicron infection

Authors (36)
Lancet Infectious Diseases
Published
Crick labs/ facilities
Full details

Human endogenous retrovirus onco-exaptation counters cancer cell senescence through calbindin

Authors (14)
Journal of Clinical Investigation
Published
Crick labs/ facilities
Full details

Sotrovimab restores neutralization against current Omicron subvariants in patients with blood cancer

Authors (67)
Cancer Cell
Published
Crick labs/ facilities
Full details

Tracking early lung cancer metastatic dissemination in TRACERx using ctDNA

Authors (55)
Nature
Published
Crick labs/ facilities
Full details

Antibodies against endogenous retroviruses promote lung cancer immunotherapy

Authors (51)
Nature
Published
Crick labs/ facilities
Full details

Evolutionary characterization of lung adenocarcinoma morphology in TRACERx

Authors (53)
Nature Medicine
Published
Crick labs/ facilities
Full details

Genomic-transcriptomic evolution in lung cancer and metastasis

Authors (47)
Nature
Published
Crick labs/ facilities
Full details

Lung adenocarcinoma promotion by air pollutants

Authors (72)
Nature
Published
Crick labs/ facilities
Full details

Functional immune responses against SARS-CoV-2 variants of concern after fourth COVID-19 vaccine dose or infection in patients with blood cancer

Authors (64)
Cell Reports Medicine
Published
Crick labs/ facilities
Full details

An immunogenic model of KRAS-mutant lung cancer enables evaluation of targeted therapy and immunotherapy combinations

Authors (26)
Cancer Research
Published
Crick labs/ facilities
Full details

SARS-CoV-2 S2-targeted vaccination elicits broadly neutralizing antibodies

Authors (21)
Science Translational Medicine
Published
Crick labs/ facilities
Full details